Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine.
Oncotarget
Cabezón, Marta M; Bargay, Joan J; Xicoy, Blanca B; García, Olga O; Borrás, Josep J; Tormo, Mar M; Marcé, Sílvia S; Pedro, Carme C; Valcárcel, David D; Jiménez, Maria-José MJ; Guàrdia, Ramón R; Palomo, Laura L; Brunet, Salut S; Vall-Llovera, Ferran F; Garcia, Antoni A; Feliu, Evarist E; Zamora, Lurdes L; ,